Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Dec 14, 2020 10:04pm
104 Views
Post# 32106325

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:AGN halted

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:AGN halted
Minty_33 wrote:
And so you're saying that with all the heart healthy positives regarding beta glucan, not one of these many players as you say, thought about doing a similar test similar to what the MHI is doing? Highly doubtful.


Having spoken to Gilles on this, no, no one else has done clinical studies and published results on heart health benefits of BG. This is being done for marketing as anyone can make unsubstantiated general claims on the benefits of BG.

As for FT on BNN, he wanted to make a quick dollar in a pump and dump but Gilles didn't want to jump on the cannabis hype. That was not the game plan for Ceapro.

As for the licensing deal, let's see what happens in the next few weeks. If nothing happens, I hope an update as to why is given.
<< Previous
Bullboard Posts
Next >>